Literature DB >> 924012

Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis.

V C Jordan, G Prestwich.   

Abstract

The interaction of the antioestrogen tamoxifen with rat uterine oestrogen receptor has been studied using swinging bucket and vertical tube rotor techniques of sucrose density gradient analysis. Tamoxifen inhibits the binding of [3H]oestradiol to the 8S oestrogen receptor protein whereas using the swinging bucket rotor technique of sucrose density gradient analysis [3H]-tamoxifen appears to bind to an oestradiol specific protein which sediments at 4-5S. In contrast, using rapid sucrose density gradient analysis with a vertical tube rotor [3H]tamoxifen shows oestrogen specific binding in the 8S region. It is suggested that conventional techniques of sucrose density gradient analysis are unsuited for the investigation of the low affinity ligand interactions with oestrogen receptor proteins since rapid dissociation of complexes can result in ligand binding to nonreceptor proteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 924012     DOI: 10.1016/0303-7207(77)90090-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

2.  A comparison, at the cellular and subcellular levels, of the effects of tamoxifen and oestradiol benzoate on the immature rat uterus [proceedings].

Authors:  E R Clark; C J Dix; V C Jordan; G Prestwich; S Sexton
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

Review 3.  The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-10-22       Impact factor: 5.678

Review 4.  Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.

Authors:  A C Tate; E R DeSombre; G L Greene; E V Jensen; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 6.  Tamoxifen: catalyst for the change to targeted therapy.

Authors:  V Craig Jordan
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

7.  Target organ-specific inactivation of drug metabolizing enzymes in kidney of hamsters treated with estradiol.

Authors:  D Roy; J G Liehr
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

Review 8.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

9.  Influence of 17- alpha-estradiol on catecholamine secretion from the perfused rat adrenal gland.

Authors:  Y H Park; G S Cho; E T Cho; Y K Park; M J Lee; J Y Chung; S P Hong; J J Lee; Y Jang; H J Yoo; C H Choi; D Y Lim
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

10.  Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

Authors:  R Callaghan; C F Higgins
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.